2025
SJR Q2
JCR Q2 · 3,4
OA
22 matched articles
SCIE
Journal detail
Journal of Cancer
- Publisher
- Ivyspring International Publisher
- Country
- Australia · Pacific Region
- Type
- journal
- ISSN
-
18379664
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,852
- Quartile Q2
- H-Index 99
- Cites/doc 3,19
- Docs (3y) 1.157
- Cites (3y) 3.929
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,4
- 5Y JIF 3,5
- JCI 0,75
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Oncology Q2
Areas
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,852 | 3,4 | 3,5 | 0,75 | Q2 | 99 |
| 2024 | Q2 | Q2 | 0,903 | 3,2 | 3,2 | 0,71 | Q2 | 89 |
| 2023 | Q2 | Q2 | 0,901 | 3,3 | 3,4 | 0,79 | Q2 | 89 |
| 2022 | Q2 | Q2 | 0,905 | 3,9 | 3,9 | 0,77 | Q2 | 89 |
| 2021 | Q2 | Q2 | 0,904 | 4,5 | 4,5 | 0,81 | Q2 | 89 |
| 2020 | Q2 | Q2 | 1,19 | 4,2 | 4,3 | 0,78 | Q2 | 89 |
| 2019 | Q2 | Q2 | 1,142 | 3,6 | 3,6 | 0,82 | Q2 | 89 |
| 2018 | — | Q2 | — | 3,2 | 3,1 | 0,78 | Q2 | — |
| 2017 | Q2 | Q2 | 1,159 | 3,2 | 3,4 | 0,82 | Q2 | 89 |
| 2016 | Q2 | Q3 | 1,207 | 2,9 | 3,1 | — | — | 89 |
| 2015 | Q1 | Q2 | 1,437 | 3,6 | 3,2 | — | — | 89 |
| 2014 | Q1 | Q2 | 1,312 | 3,3 | 3 | — | — | 89 |
| 2013 | Q2 | Q3 | 1,17 | 2,6 | 2,7 | — | — | 89 |
| 2012 | Q2 | — | 0,873 | — | — | — | — | 89 |
| 2011 | Q2 | — | 0,6 | — | — | — | — | 89 |
| 2010 | — | — | — | — | — | — | — | 89 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q2 | Q2 | 148/333 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q2 | 130/328 |
| 2023 | ONCOLOGY | SCIE | Q2 | Q2 | 118/322 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q2 | 103/241 |
| 2021 | ONCOLOGY | SCIE | Q2 | Q2 | 115/245 |
| 2020 | ONCOLOGY | SCIE | Q2 | Q2 | 120/242 |
| 2019 | ONCOLOGY | SCIE | Q2 | Q2 | 105/244 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q2 | 105/230 |
| 2017 | ONCOLOGY | SCIE | Q2 | Q2 | 109/223 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 113/217 |
| 2015 | ONCOLOGY | SCIE | Q2 | — | 73/213 |
| 2014 | ONCOLOGY | SCIE | Q2 | — | 84/211 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 104/203 |